| Business Summary | | Synthetech,
Inc.
produces
chemically
modified
naturally
occurring
and
synthetic
amino
acids
which
it
refers
to
as
"Peptide
Building
Blocks"
(PBBs).
Synthetech's
PBBs
are
used
in
peptide,
peptidomimetic
small
molecule
and
other
drugs
under
development
and
on
the
market
for
the
treatment
of
AIDS,
cancer,
cardiovascular
and
other
diseases.
The
Company
also
is
manufacturing
PBBs
for
use
in
a
cosmeceutical,
a
cosmetic
product
that
makes
no
therapeutic
claims
but
being
intended
for
human
use
is
regulated
by
the
FDA
for
human
safety. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | NZYM
specializes
in
developing
and
producing
Peptide
Building
Blocks
(PBBs),
which
are
chemically
modified
forms
of
natural
amino
acids
and
synthetic
non-natural
amino
acids
using
a
combination
of
organic
chemistry
and
biocatalysis.
For
the
three
months
ended
6/30/01,
revenues
fell
14%
to
$2.3
million.
Net
loss
totalled
$327
thousand
vs.
an
income
of
$354
thousand.
Results
reflect
reduced
revenue
from
large-scale
orders
and
lower
gross
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| Paul Ahrens, 49 Chairman | -- | M. Sreenivasan, 52 Pres,
CEO | $214K | Charles Williams, 54 CFO,
VP of Fin. and Admin., Sec., Treasurer, Directo | 124K | Michael Cannarsa, Ph.D., 44 Director
of Bus. Devel. | -- | Joel Melka, 46 Director
of Manufacturing | 108K | Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|